clinical trials and novel agents under investigation in t-cell lymphoma
Published 1 year ago • 66 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
1:54
novel treatment strategies in t-cell lymphomas
-
3:31
upcoming trials and agents in t-cell lymphoma
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
6:32
pathobiology and clinical management of t-cell lymphoma
-
7:50
updates from the lymphoma & cll session: clinical trials, novel agents, and more
-
1:48
novel immunotherapy approaches in lymphoma: car-t cells, bispecifics & sequencing
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
7:52
highlights in t-cell lymphoma: unmet needs, clinical trial updates, and future outlooks
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
4:13
medi-570: a novel antibody therapy in r/r t-cell lymphoma
-
1:30
upcoming results from clinical trials for treating relapsed, low grade lymphoma
-
2:49
identifying novel antigens for tcr t-cell therapy
-
1:06
an ongoing phase i trial evaluating as-1763, a novel non-covalent btki, in b-cell lymphomas
-
2:48
btk inhibitors in the treatment of dlbcl: trials investigating these agents
-
1:44
upcoming trials and novel agents in mpns
-
2:39
overview of the lumiere clinical trial in peripheral t-cell lymphoma
-
1:21
novel approaches to harnessing the immune system in lymphoma